about
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactionsEvidence for specific suppression in the maintenance of immunologic tolerance.Antigen recognition by T-cells and its suppression. Significance and origin of rosette-forming cells.Differentiation of mouse plasmocytomas in vitro: two phenotypically stabilized variants of the same cell.Transplantation tolerance-where do we stand?Antigen-induced proliferative response to murine thymus cells in vitroThymus-independence of slowly metabolized immunogensReprogramming the immune system.Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regionsT and B lymphocytes in mice studied by using antisera against surface antigenic markers.Design of effective immunotherapy for human autoimmunity.Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes.The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins.Antigen-specific cells in mouse bone marrow. II. Fluctuation of the number and potential of immunocyte precursors after immunization.Immunologic memory cells of bone marrow origin. Increased burst size of specific immunocyte precursors.Surface immunoglobulins on thymus and thymus-derived lymphoid cells.Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates.Contribution of bone marrow cells and lack of expression of thymocytes in genetic controls of immune responses for two immunopotent regions within poly-(Phe,Glu)-poly-Pro--poly-Lys in inbred mouse strains.Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin).Splenic replenishment of synergistic ability to bone marrow and thymic cells of neonatally splenectomized CBA miceThe role of thymocytes and bone marrow cells in defining the response to the dinitrophenyl hapten attached to positively and negatively charged synthetic polypeptide carriers. Cell fractionation over charged columnsThe ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parametersRoles of T and B lymphocytes in the termination of unresponsiveness to autologous thyroglobulin in mice.Antigen-specific cells in mouse bone marrow. I. Lasting effects of priming on immunocyte production by transferred marrow.Immunological memory in mice. 3. Memory to heterologous erythrocytes in both T cell and B cell populations and requirement for T cells in expression of B cell memory. Evidence using immunoglobulin allotype and mouse alloantigen theta markers with coT and B cell in hapten-specific carrier-determined tolerance.In vivo induction of tolerance in murine CD4+ cell subsetsMice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivoMechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.Memory cell generation ablated by soluble protein antigen by means of effects on T- and B-lymphocyte compartments.Selection, memory and selective memories: T cells, B cells and Sir Mac 1968.Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis.Epitope-specific tolerance induction with an engineered immunoglobulin.A Nonadjuvanted IgG2a Monoclonal Antibody against Nucleosomes Elicits Potent T Cell-Dependent, Idiotype-Specific IgG1 Responses and Glomerular IgG1/IgG2a Deposits in Normal Mice.In vitro tolerance induction of neonatal murine B cellsCell cooperation in the immune response.Strategies for treatment of myasthenia gravis.Surface antigens of immunocompetent cells. I. Effect of theta and PC.1 alloantisera on the ability of spleen cells to transfer immune responsesRapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro.Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses.
P2860
Q28362747-4DFB51F8-D861-4649-B6AC-7C402C78F989Q30442766-5BDC8305-00AF-43E3-B9C3-6A74F36EDC05Q33567956-3096E31C-ECF3-4DAB-84D7-E996F27855FBQ33707275-C1E68CA1-F0BB-43D4-9F24-23FC8EE88227Q33764678-97DDCDD7-7F98-4308-9319-7960F72EFB7DQ34502225-DB7AC90F-F052-473E-8814-E329B4A3E612Q34730088-BF1CAF5D-8D03-434B-9851-9CC7E214FD7DQ34792489-083392C2-8437-42FE-947F-5756814161F8Q36012271-EAE40338-5F4F-40B6-8CD0-3E2007D2348AQ36101427-8853C446-BE53-47CA-90E7-D5F044BB3C76Q36148416-5176BE35-500B-4CD5-A653-CC5EF90DCAAEQ36257660-E37B1742-9E5D-4CF8-8227-13331C4A6B64Q36270044-E516308F-D3F3-42E8-A375-7A15C84E7DFFQ36270710-B3364A1A-04DA-46DD-8A41-C5CA83550EB5Q36270975-F49D26EA-83EE-4391-BABC-2B5E654D28FCQ36271013-6899ED95-6139-4BD3-A960-A629E671ABA1Q36271140-5B4BD321-5A96-496F-B2DC-7607C78A439AQ36271166-1A8568D1-6013-4612-B800-E6266C21061DQ36271879-A8EF0815-DC0E-46E6-9A42-1A17B68D3D68Q36271990-A44EC780-CD3C-43AB-B765-DFF702DB3250Q36272318-38AFE776-6F92-476B-8A34-3AFD049D4F88Q36272666-F611B241-F36D-409B-9AE4-CCE38115FB89Q36272961-0938A28E-CBCE-42E1-AD7A-40DB50DB2914Q36334755-9DC5C30E-9019-4880-95A8-C361A3ADFBB8Q36334822-EA71E366-226F-46E6-B2C7-BDE0993F0A7CQ36358530-3469A3FD-F8CC-4DFD-8D72-CC462E441442Q36362537-6950A866-C217-431D-9295-FD3321CC2569Q36362877-707870E6-1A31-4365-8A66-1EE252A8A0B3Q36707550-7EC68489-35EB-4DCE-BF53-BB9D45F4AE41Q36940540-2E9ACC79-6651-4B00-B243-14A7CF905D43Q37015265-A2C691CD-3D7D-4EF2-B696-111C6E246CF3Q37522009-7474A42C-D704-48F3-933D-7FA58FF6A565Q37612708-D1F8D827-20B7-4805-B96A-D211F5763EF4Q38737661-BA4D992F-48CF-4EFD-AFBE-06535D852B68Q39381132-8E4DADC7-D065-4C9D-B8D0-3C2E7A78056EQ39866370-DE4F157D-A518-4962-870D-6D958D3C1A4AQ40838126-49348A02-C8C0-4A84-967F-ECF7EDEA919DQ41902902-7ABD602D-824A-4E76-B8BB-F2B880116468Q41914115-C8161D9D-5645-42E1-A7EF-648038152685Q41921458-9B0FE261-1662-440F-9030-71926A66D92C
P2860
description
1970 nî lūn-bûn
@nan
1970 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի մարտին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
Cellular sites of immunologic unresponsiveness.
@ast
Cellular sites of immunologic unresponsiveness.
@en
type
label
Cellular sites of immunologic unresponsiveness.
@ast
Cellular sites of immunologic unresponsiveness.
@en
prefLabel
Cellular sites of immunologic unresponsiveness.
@ast
Cellular sites of immunologic unresponsiveness.
@en
P2093
P2860
P356
P1476
Cellular sites of immunologic unresponsiveness.
@en
P2093
P2860
P304
P356
10.1073/PNAS.65.3.551
P407
P577
1970-03-01T00:00:00Z